ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bispecific Antibodies for Cancer Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-27I7070
Home | Market Reports | Health| Health Conditions| Cancer
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2028
BUY CHAPTERS

Global Bispecific Antibodies for Cancer Market Research Report 2024

Code: QYRE-Auto-27I7070
Report
January 2024
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus NV
Regeneron Pharmaceuticals

Bispecific Antibodies for Cancer Market

Bispecific antibodies can simultaneously address two different antigens, which are sufficient to target two trails involved in cancer pathogenesis, and therefore, provide advantages over monoclonal antibodies therapy.
The global Bispecific Antibodies for Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bispecific Antibodies for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bispecific Antibodies for Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bispecific Antibodies for Cancer include Amgen, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus and Regeneron Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies for Cancer.

Report Scope

The Bispecific Antibodies for Cancer market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bispecific Antibodies for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bispecific Antibodies for Cancer manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bispecific Antibodies for Cancer Market Report

Report Metric Details
Report Name Bispecific Antibodies for Cancer Market
Segment by Type
  • CD19/CD3
  • CD30/CD16A
Segment by Application
  • Hospital
  • Pharmaceutical Companies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus, Regeneron Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bispecific Antibodies for Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bispecific Antibodies for Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bispecific Antibodies for Cancer Market report?

Ans: The main players in the Bispecific Antibodies for Cancer Market are Amgen, Astella Pharma, Ben Kang Biopharmaceutical (Shenzhen), Merus, Regeneron Pharmaceuticals

What are the Application segmentation covered in the Bispecific Antibodies for Cancer Market report?

Ans: The Applications covered in the Bispecific Antibodies for Cancer Market report are Hospital, Pharmaceutical Companies, Other

What are the Type segmentation covered in the Bispecific Antibodies for Cancer Market report?

Ans: The Types covered in the Bispecific Antibodies for Cancer Market report are CD19/CD3, CD30/CD16A

1 Bispecific Antibodies for Cancer Market Overview
1.1 Product Overview and Scope of Bispecific Antibodies for Cancer
1.2 Bispecific Antibodies for Cancer Segment by Type
1.2.1 Global Bispecific Antibodies for Cancer Market Value Comparison by Type (2024-2030)
1.2.2 CD19/CD3
1.2.3 CD30/CD16A
1.3 Bispecific Antibodies for Cancer Segment by Application
1.3.1 Global Bispecific Antibodies for Cancer Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Bispecific Antibodies for Cancer Market Size Estimates and Forecasts
1.4.1 Global Bispecific Antibodies for Cancer Revenue 2019-2030
1.4.2 Global Bispecific Antibodies for Cancer Sales 2019-2030
1.4.3 Global Bispecific Antibodies for Cancer Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bispecific Antibodies for Cancer Market Competition by Manufacturers
2.1 Global Bispecific Antibodies for Cancer Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bispecific Antibodies for Cancer Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bispecific Antibodies for Cancer Average Price by Manufacturers (2019-2024)
2.4 Global Bispecific Antibodies for Cancer Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bispecific Antibodies for Cancer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bispecific Antibodies for Cancer, Product Type & Application
2.7 Bispecific Antibodies for Cancer Market Competitive Situation and Trends
2.7.1 Bispecific Antibodies for Cancer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bispecific Antibodies for Cancer Players Market Share by Revenue
2.7.3 Global Bispecific Antibodies for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bispecific Antibodies for Cancer Retrospective Market Scenario by Region
3.1 Global Bispecific Antibodies for Cancer Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bispecific Antibodies for Cancer Global Bispecific Antibodies for Cancer Sales by Region: 2019-2030
3.2.1 Global Bispecific Antibodies for Cancer Sales by Region: 2019-2024
3.2.2 Global Bispecific Antibodies for Cancer Sales by Region: 2025-2030
3.3 Global Bispecific Antibodies for Cancer Global Bispecific Antibodies for Cancer Revenue by Region: 2019-2030
3.3.1 Global Bispecific Antibodies for Cancer Revenue by Region: 2019-2024
3.3.2 Global Bispecific Antibodies for Cancer Revenue by Region: 2025-2030
3.4 North America Bispecific Antibodies for Cancer Market Facts & Figures by Country
3.4.1 North America Bispecific Antibodies for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bispecific Antibodies for Cancer Sales by Country (2019-2030)
3.4.3 North America Bispecific Antibodies for Cancer Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bispecific Antibodies for Cancer Market Facts & Figures by Country
3.5.1 Europe Bispecific Antibodies for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bispecific Antibodies for Cancer Sales by Country (2019-2030)
3.5.3 Europe Bispecific Antibodies for Cancer Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bispecific Antibodies for Cancer Market Facts & Figures by Country
3.6.1 Asia Pacific Bispecific Antibodies for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bispecific Antibodies for Cancer Sales by Country (2019-2030)
3.6.3 Asia Pacific Bispecific Antibodies for Cancer Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bispecific Antibodies for Cancer Market Facts & Figures by Country
3.7.1 Latin America Bispecific Antibodies for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bispecific Antibodies for Cancer Sales by Country (2019-2030)
3.7.3 Latin America Bispecific Antibodies for Cancer Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bispecific Antibodies for Cancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Bispecific Antibodies for Cancer Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bispecific Antibodies for Cancer Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bispecific Antibodies for Cancer Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bispecific Antibodies for Cancer Sales by Type (2019-2030)
4.1.1 Global Bispecific Antibodies for Cancer Sales by Type (2019-2024)
4.1.2 Global Bispecific Antibodies for Cancer Sales by Type (2025-2030)
4.1.3 Global Bispecific Antibodies for Cancer Sales Market Share by Type (2019-2030)
4.2 Global Bispecific Antibodies for Cancer Revenue by Type (2019-2030)
4.2.1 Global Bispecific Antibodies for Cancer Revenue by Type (2019-2024)
4.2.2 Global Bispecific Antibodies for Cancer Revenue by Type (2025-2030)
4.2.3 Global Bispecific Antibodies for Cancer Revenue Market Share by Type (2019-2030)
4.3 Global Bispecific Antibodies for Cancer Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bispecific Antibodies for Cancer Sales by Application (2019-2030)
5.1.1 Global Bispecific Antibodies for Cancer Sales by Application (2019-2024)
5.1.2 Global Bispecific Antibodies for Cancer Sales by Application (2025-2030)
5.1.3 Global Bispecific Antibodies for Cancer Sales Market Share by Application (2019-2030)
5.2 Global Bispecific Antibodies for Cancer Revenue by Application (2019-2030)
5.2.1 Global Bispecific Antibodies for Cancer Revenue by Application (2019-2024)
5.2.2 Global Bispecific Antibodies for Cancer Revenue by Application (2025-2030)
5.2.3 Global Bispecific Antibodies for Cancer Revenue Market Share by Application (2019-2030)
5.3 Global Bispecific Antibodies for Cancer Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Bispecific Antibodies for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Bispecific Antibodies for Cancer Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Astella Pharma
6.2.1 Astella Pharma Corporation Information
6.2.2 Astella Pharma Description and Business Overview
6.2.3 Astella Pharma Bispecific Antibodies for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astella Pharma Bispecific Antibodies for Cancer Product Portfolio
6.2.5 Astella Pharma Recent Developments/Updates
6.3 Ben Kang Biopharmaceutical (Shenzhen)
6.3.1 Ben Kang Biopharmaceutical (Shenzhen) Corporation Information
6.3.2 Ben Kang Biopharmaceutical (Shenzhen) Description and Business Overview
6.3.3 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Product Portfolio
6.3.5 Ben Kang Biopharmaceutical (Shenzhen) Recent Developments/Updates
6.4 Merus
6.4.1 Merus Corporation Information
6.4.2 Merus Description and Business Overview
6.4.3 Merus Bispecific Antibodies for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merus Bispecific Antibodies for Cancer Product Portfolio
6.4.5 Merus Recent Developments/Updates
6.5 Regeneron Pharmaceuticals
6.5.1 Regeneron Pharmaceuticals Corporation Information
6.5.2 Regeneron Pharmaceuticals Description and Business Overview
6.5.3 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Product Portfolio
6.5.5 Regeneron Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bispecific Antibodies for Cancer Industry Chain Analysis
7.2 Bispecific Antibodies for Cancer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bispecific Antibodies for Cancer Production Mode & Process
7.4 Bispecific Antibodies for Cancer Sales and Marketing
7.4.1 Bispecific Antibodies for Cancer Sales Channels
7.4.2 Bispecific Antibodies for Cancer Distributors
7.5 Bispecific Antibodies for Cancer Customers
8 Bispecific Antibodies for Cancer Market Dynamics
8.1 Bispecific Antibodies for Cancer Industry Trends
8.2 Bispecific Antibodies for Cancer Market Drivers
8.3 Bispecific Antibodies for Cancer Market Challenges
8.4 Bispecific Antibodies for Cancer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amgen Inc
Astella Pharma
Ben Kang Biopharmaceutical (Shenzhen)
Merus NV
Regeneron Pharmaceuticals
List of Tables
    Table 1. Global Bispecific Antibodies for Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Bispecific Antibodies for Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Bispecific Antibodies for Cancer Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Bispecific Antibodies for Cancer Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Bispecific Antibodies for Cancer Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Bispecific Antibodies for Cancer Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Bispecific Antibodies for Cancer Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Bispecific Antibodies for Cancer Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Bispecific Antibodies for Cancer, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Bispecific Antibodies for Cancer, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Bispecific Antibodies for Cancer, Product Type & Application
    Table 12. Global Key Manufacturers of Bispecific Antibodies for Cancer, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Bispecific Antibodies for Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibodies for Cancer as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Bispecific Antibodies for Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Bispecific Antibodies for Cancer Sales by Region (2019-2024) & (K Units)
    Table 18. Global Bispecific Antibodies for Cancer Sales Market Share by Region (2019-2024)
    Table 19. Global Bispecific Antibodies for Cancer Sales by Region (2025-2030) & (K Units)
    Table 20. Global Bispecific Antibodies for Cancer Sales Market Share by Region (2025-2030)
    Table 21. Global Bispecific Antibodies for Cancer Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Bispecific Antibodies for Cancer Revenue Market Share by Region (2019-2024)
    Table 23. Global Bispecific Antibodies for Cancer Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Bispecific Antibodies for Cancer Revenue Market Share by Region (2025-2030)
    Table 25. North America Bispecific Antibodies for Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Bispecific Antibodies for Cancer Sales by Country (2019-2024) & (K Units)
    Table 27. North America Bispecific Antibodies for Cancer Sales by Country (2025-2030) & (K Units)
    Table 28. North America Bispecific Antibodies for Cancer Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Bispecific Antibodies for Cancer Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Bispecific Antibodies for Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Bispecific Antibodies for Cancer Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Bispecific Antibodies for Cancer Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Bispecific Antibodies for Cancer Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Bispecific Antibodies for Cancer Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Bispecific Antibodies for Cancer Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Bispecific Antibodies for Cancer Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Bispecific Antibodies for Cancer Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Bispecific Antibodies for Cancer Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Bispecific Antibodies for Cancer Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Bispecific Antibodies for Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Bispecific Antibodies for Cancer Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Bispecific Antibodies for Cancer Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Bispecific Antibodies for Cancer Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Bispecific Antibodies for Cancer Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Bispecific Antibodies for Cancer Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Bispecific Antibodies for Cancer Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Bispecific Antibodies for Cancer Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Bispecific Antibodies for Cancer Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Bispecific Antibodies for Cancer Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Bispecific Antibodies for Cancer Sales (K Units) by Type (2019-2024)
    Table 51. Global Bispecific Antibodies for Cancer Sales (K Units) by Type (2025-2030)
    Table 52. Global Bispecific Antibodies for Cancer Sales Market Share by Type (2019-2024)
    Table 53. Global Bispecific Antibodies for Cancer Sales Market Share by Type (2025-2030)
    Table 54. Global Bispecific Antibodies for Cancer Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Bispecific Antibodies for Cancer Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Bispecific Antibodies for Cancer Revenue Market Share by Type (2019-2024)
    Table 57. Global Bispecific Antibodies for Cancer Revenue Market Share by Type (2025-2030)
    Table 58. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Bispecific Antibodies for Cancer Sales (K Units) by Application (2019-2024)
    Table 61. Global Bispecific Antibodies for Cancer Sales (K Units) by Application (2025-2030)
    Table 62. Global Bispecific Antibodies for Cancer Sales Market Share by Application (2019-2024)
    Table 63. Global Bispecific Antibodies for Cancer Sales Market Share by Application (2025-2030)
    Table 64. Global Bispecific Antibodies for Cancer Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Bispecific Antibodies for Cancer Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Bispecific Antibodies for Cancer Revenue Market Share by Application (2019-2024)
    Table 67. Global Bispecific Antibodies for Cancer Revenue Market Share by Application (2025-2030)
    Table 68. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Application (2025-2030)
    Table 70. Amgen Corporation Information
    Table 71. Amgen Description and Business Overview
    Table 72. Amgen Bispecific Antibodies for Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Amgen Bispecific Antibodies for Cancer Product
    Table 74. Amgen Recent Developments/Updates
    Table 75. Astella Pharma Corporation Information
    Table 76. Astella Pharma Description and Business Overview
    Table 77. Astella Pharma Bispecific Antibodies for Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Astella Pharma Bispecific Antibodies for Cancer Product
    Table 79. Astella Pharma Recent Developments/Updates
    Table 80. Ben Kang Biopharmaceutical (Shenzhen) Corporation Information
    Table 81. Ben Kang Biopharmaceutical (Shenzhen) Description and Business Overview
    Table 82. Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Ben Kang Biopharmaceutical (Shenzhen) Bispecific Antibodies for Cancer Product
    Table 84. Ben Kang Biopharmaceutical (Shenzhen) Recent Developments/Updates
    Table 85. Merus Corporation Information
    Table 86. Merus Description and Business Overview
    Table 87. Merus Bispecific Antibodies for Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Merus Bispecific Antibodies for Cancer Product
    Table 89. Merus Recent Developments/Updates
    Table 90. Regeneron Pharmaceuticals Corporation Information
    Table 91. Regeneron Pharmaceuticals Description and Business Overview
    Table 92. Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Regeneron Pharmaceuticals Bispecific Antibodies for Cancer Product
    Table 94. Regeneron Pharmaceuticals Recent Developments/Updates
    Table 95. Key Raw Materials Lists
    Table 96. Raw Materials Key Suppliers Lists
    Table 97. Bispecific Antibodies for Cancer Distributors List
    Table 98. Bispecific Antibodies for Cancer Customers List
    Table 99. Bispecific Antibodies for Cancer Market Trends
    Table 100. Bispecific Antibodies for Cancer Market Drivers
    Table 101. Bispecific Antibodies for Cancer Market Challenges
    Table 102. Bispecific Antibodies for Cancer Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Bispecific Antibodies for Cancer
    Figure 2. Global Bispecific Antibodies for Cancer Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Bispecific Antibodies for Cancer Market Share by Type in 2023 & 2030
    Figure 4. CD19/CD3 Product Picture
    Figure 5. CD30/CD16A Product Picture
    Figure 6. Global Bispecific Antibodies for Cancer Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Bispecific Antibodies for Cancer Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Pharmaceutical Companies
    Figure 10. Other
    Figure 11. Global Bispecific Antibodies for Cancer Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Bispecific Antibodies for Cancer Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Bispecific Antibodies for Cancer Sales (2019-2030) & (K Units)
    Figure 14. Global Bispecific Antibodies for Cancer Average Price (USD/Unit) & (2019-2030)
    Figure 15. Bispecific Antibodies for Cancer Report Years Considered
    Figure 16. Bispecific Antibodies for Cancer Sales Share by Manufacturers in 2023
    Figure 17. Global Bispecific Antibodies for Cancer Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Bispecific Antibodies for Cancer Players: Market Share by Revenue in 2023
    Figure 19. Bispecific Antibodies for Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Bispecific Antibodies for Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Bispecific Antibodies for Cancer Sales Market Share by Country (2019-2030)
    Figure 22. North America Bispecific Antibodies for Cancer Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Bispecific Antibodies for Cancer Sales Market Share by Country (2019-2030)
    Figure 26. Europe Bispecific Antibodies for Cancer Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Bispecific Antibodies for Cancer Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Bispecific Antibodies for Cancer Revenue Market Share by Region (2019-2030)
    Figure 34. China Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Bispecific Antibodies for Cancer Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Bispecific Antibodies for Cancer Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Bispecific Antibodies for Cancer Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Bispecific Antibodies for Cancer Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. U.A.E Bispecific Antibodies for Cancer Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Bispecific Antibodies for Cancer by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Bispecific Antibodies for Cancer by Type (2019-2030)
    Figure 56. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Bispecific Antibodies for Cancer by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Bispecific Antibodies for Cancer by Application (2019-2030)
    Figure 59. Global Bispecific Antibodies for Cancer Price (USD/Unit) by Application (2019-2030)
    Figure 60. Bispecific Antibodies for Cancer Value Chain
    Figure 61. Bispecific Antibodies for Cancer Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Oncology Imaging Equipment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1U15802
Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global HER2 Tumor Marker Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27D15553
Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Targeted Radiotherapy Drug Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2U15903
Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2W15676
Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions